Top in endocrinology: Bisphenol A exposure, lower-dose pioglitazone
Click Here to Manage Email Alerts
The Endocrine Society and other organizations recently called on the FDA to lower its limit on the endocrine-disrupting chemical bisphenol A, or BPA, in food contact articles.
The FDA’s current limit on BPA is 50 µg/kg of body weight. However, according to a draft opinion published by the European Food Safety Authority, exposure to BPA at a level 5,000 times lower can cause harmful effects. It was the top story in endocrinology last week.
Another top story was about a post-hoc analysis that showed lower doses of pioglitazone had similar efficacy as 45 mg of pioglitazone in preventing new-onset diabetes, stroke and myocardial infarction.
Read these and more top stories in endocrinology below:
Endocrine Society petitions FDA to lower limit on bisphenol A
The Endocrine Society has teamed up with other organizations to ask the FDA to strengthen its limits on bisphenol A in adhesives and coatings after new findings showed a lower level of exposure to the chemical can cause health risks. Read more.
Similar efficacy, lower adverse event risk with lower doses of pioglitazone
Both 15 mg and 30 mg pioglitazone doses have similar efficacy as 45 mg for preventing new-onset diabetes, stroke and myocardial infarction but with lower risk for adverse events, according to study findings. Read more.
Legal victory helps to keep children with diabetes stay safe at school
How often do you expect to hear the statement, “The plaintiffs did not seek any monetary damages”? The truth is, rarely. Read more.
Mediterranean diet may preserve kidney function better than low-fat for adults with CHD
Adults with coronary heart disease who followed a Mediterranean diet preserved their kidney function better than those who followed a low-fat diet for 5 years, according to study data published in Clinical Nutrition. Read more.
CV risk factors high among young adults with youth-onset type 2 diabetes
Young adults with youth-onset type 2 diabetes developed multiple cardiovascular risk factors during a decade of follow-up, according to an analysis of follow-up data from the TODAY study. Read more.